Colorectal Cancer Awareness Month 2020
Thursday, February 27, 2020 - 08:00am
March is Colorectal Cancer Awareness Month, and Pfizer is working to raise awareness of metastatic colorectal cancer and the importance of biomarker testing.
Only four months after her husband passed away from cancer, Karen was diagnosed with colorectal cancer. Karen had been previously misdiagnosed before her doctors decided to do a colonoscopy, and following that, she found out she had rectal cancer.
Shortly after her diagnosis, Karen underwent biomarker testing. Tests revealed that she had a specific type of mutant colorectal cancer, which typically results in a poor prognosis.
Click on the video below to hear Karen discuss her diagnosis with metastatic colorectal cancer and the importance of biomarker testing.
Recent Updates and Statements
05.31.2023 Diseases & Conditions Lyme Disease Research U.S. Travel Update: Lyme Disease in Europe 05.26.2023 Cancer Diseases & Conditions Research Pfizer to Share Oncology Advancements at ASCO Annual Meeting 05.26.2023 Vaccines Pfizer and BioNTech Provide Update on COVID-19 Vaccine Supply Agreement with the European Commission 05.18.2023 Covid-19 Partnerships Research Research!America Offers $200k Discovery | Innovation | Health Prize for COVID-19 Innovator 05.16.2023 Diversity & Inclusion Employees Pfizer Culture Events in NYC and Italy Spotlight Disability Inclusion